Boston Scientific | BSX - Trade Debtors


Boston Scientific reported $2.93B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Abbott USD 10.57B 171M Dec/2025
AtriCure USD 71.31M 4.66M Mar/2026
Avanos Medical USD 103M 800K Mar/2026
Baxter International USD 1.7B 310M Mar/2026
Becton, Dickinson and Co. USD 2.51B 486M Dec/2025
Boston Scientific USD 2.93B 98M Dec/2025
CONMED USD 247.83M 22.89M Dec/2025
Cooper Companies USD 807.1M 21.9M Dec/2025
Danaher USD 4.76B 845M Mar/2026
Dexcom USD 1.09B 182.1M Mar/2026
Edwards Lifesciences USD 912.1M 19.3M Dec/2025
Globus Medical USD 743.66M 55.54M Dec/2025
Illumina USD 738M 116M Mar/2026
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 516.9M 54.7M Dec/2025
Integra LifeSciences USD 264.41M 14.44M Mar/2026
Intuitive Surgical USD 1.6B 68.3M Mar/2026
J&J USD 21.33B 3.72B Dec/2025
Masimo USD 391.9M 36M Dec/2025
Medtronic USD 6.36B 30M Dec/2025
Merit Medical Systems USD 227M 3.39M Mar/2026
Stryker USD 3.57B 468M Mar/2026
Tandem Diabetes Care USD 165.49M 39.55M Dec/2025
Teleflex USD 345.58M 247.07M Dec/2025
Zimmer Biomet Holdings USD 1.73B 24.2M Mar/2026